SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-07-058779
Filing Date
2007-08-03
Accepted
2007-08-03 16:37:37
Documents
7
Period of Report
2007-07-31
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K a07-21041_18k.htm 8-K 37395
2 EX-10.1 a07-21041_1ex10d1.htm EX-10.1 44268
3 EX-10.2 a07-21041_1ex10d2.htm EX-10.2 44265
4 EX-10.3 a07-21041_1ex10d3.htm EX-10.3 44222
5 EX-10.4 a07-21041_1ex10d4.htm EX-10.4 43792
6 EX-10.5 a07-21041_1ex10d5.htm EX-10.5 44013
7 EX-10.6 a07-21041_1ex10d6.htm EX-10.6 44221
  Complete submission text file 0001104659-07-058779.txt   303878
Mailing Address 125 CAMBRIDGEPARK DRIVE, 6TH FLOOR CAMBRIDGE MA 02140
Business Address 125 CAMBRIDGEPARK DRIVE, 6TH FLOOR CAMBRIDGE MA 02140 6174972070
AMAG PHARMACEUTICALS INC. (Filer) CIK: 0000792977 (see all company filings)

IRS No.: 042742593 | State of Incorp.: DE | Fiscal Year End: 0930
Type: 8-K | Act: 34 | File No.: 000-14732 | Film No.: 071024486
SIC: 2835 In Vitro & In Vivo Diagnostic Substances